Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Human Sodium Phosphate Transporter 4 (hNPT4/SLC17A3) as a Common Renal Secretory Pathway for Drugs and Urate
In obese mice, 14 days of BRP treatment led to fat loss without changes in behavior, anxiety levels, or fecal production
This can include sticking to the dose escalation schedule of your medication
Broad disease impact beyond weight control with meaningful benefits in diseases such as cardiovascular disease, chronic kidney disease, liver disease, osteoarthritis, sleep apnea, neurodegeneration, and more
US$ 27.85
US$ 22.10
US$ 22.17
US$ 20.10
US$ 28.26
